AG
SAGE

Algert Global’s Sage Therapeutics SAGE Stock Holding History

Algert Global’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-10,700
Closed -$85.1K – 1323
2025
Q1 		$85.1K Sell
10,700
-27,596
-72% -$202K ﹤0.01% 1137
2024
Q4 		$208K Sell
38,296
-104,738
-73% -$640K ﹤0.01% 1073
2024
Q3 		$1.03M Buy
143,034
+78,190
+121% +$716K 0.03% 741
2024
Q2 		$704K Buy
64,844
+39,114
+152% +$501K 0.02% 782
2024
Q1 		$482K Hold
25,730
– – 0.02% 769
2023
Q4 		$558K Sell
25,730
-30,960
-55% -$614K 0.02% 787
2023
Q3 		$1.17M Buy
+56,690
New +$1.64M 0.05% 533
2023
Q2 		– Sell
-14,280
Closed -$599K – 1231
2023
Q1 		$599K Sell
14,280
-10,837
-43% -$466K 0.03% 778
2022
Q4 		$958K Sell
25,117
-8,520
-25% -$325K 0.05% 588
2022
Q3 		$1.32M Sell
33,637
-39,112
-54% -$1.51M 0.08% 428
2022
Q2 		$2.35M Buy
72,749
+54,077
+290% +$1.81M 0.18% 139
2022
Q1 		$618K Buy
18,672
+12,296
+193% +$462K 0.04% 736
2021
Q4 		$271K Buy
6,376
+1,040
+19% +$43.5K 0.03% 770
2021
Q3 		$236K Buy
+5,336
New +$245K 0.03% 846
2021
Q1 		– Sell
-7,310
Closed -$632K – 518
2020
Q4 		$632K Sell
7,310
-21,121
-74% -$1.56M 0.18% 184
2020
Q3 		$1.74M Sell
28,431
-28,727
-50% -$1.46M 0.55% 48
2020
Q2 		$2.38M Buy
57,158
+23,392
+69% +$849K 0.81% 14
2020
Q1 		$970K Buy
+33,766
New +$1.96M 0.41% 76

Other funds holding SAGE

MAP
Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Algert Global's SAGE Position: Q2 2025 in Review

Algert Global sold out of Sage Therapeutics (SAGE) in Q2 2025, closing a stake of 10,700 shares — an estimated $85.1K sold.

Algert Global first reported a position in SAGE in Q1 2020 and held it in 18 quarters. The position peaked at $2.38M in Q2 2020. 192 funds tracked by Wall St. Rank hold SAGE as of Q2 2025.

  • Algert Global reported no remaining Sage Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Algert Global sold 10,700 Sage Therapeutics shares in Q2 2025, an estimated $85.1K.
  • Algert Global first reported a position in Sage Therapeutics in Q1 2020 and held it in 18 quarters.
  • Algert Global's Sage Therapeutics position peaked at $2.38M in Q2 2020.
  • 192 funds tracked by Wall St. Rank held Sage Therapeutics as of Q2 2025.

Based on Algert Global's 13F filing for Q2 2025, filed 14 Aug 2025.